ELEVANCE HEALTH INC

ELV represents Elevance Health, a major U.S. health benefits company. It serves members through affiliated health plans and related businesses, including pharmacy, behavioral health, and clinical services. The company focuses on improving access and outcomes while managing costs across commercial, Medicaid, Medicare, and other government-sponsored programs.

Recent performance depends on the latest market session, so the most accurate figures are on the ELV quote page. Price moves can reflect earnings updates, health policy news, utilization trends, and broader market conditions. Reviewing price changes across multiple time frames alongside trading volume can help you understand whether moves are broad or stock-specific.

Valuation is best assessed with multiple metrics rather than a single ratio. Investors often compare ELV's price-to-earnings, price-to-sales, and price-to-book ratios with managed care peers and its own history. Cash flow-based measures and forward estimates can also add context. Current valuation inputs should be taken from the latest ELV data displayed on the page.

ELV can trade in pre-market and post-market sessions through many brokers, though liquidity is often lower and spreads wider than during regular hours. Extended-hours prices may react to after-close earnings, policy headlines, or guidance changes. Confirm your broker's extended-hours rules, order types, and eligible venues before placing trades outside regular market hours.

For a health insurer like ELV, useful metrics include revenue growth, medical loss ratio, operating margin, earnings per share, cash flow, and membership trends. The medical loss ratio helps show the share of premiums used for medical care. Balance sheet strength and capital return capacity also matter. Compare these metrics over several periods and against peers for context.

Key risks include changes in healthcare regulation and reimbursement, higher-than-expected medical utilization, pricing and competition among insurers, and integration or execution risk from acquisitions. Government program funding and policy shifts can also affect results. These factors can influence revenue, margins, and investor sentiment, so they are often central to research on ELV.